CA Patent

CA2154979A1 — Topical phenylephrine preparation

Assigned to Individual · Expires 1997-01-29 · 29y expired

What this patent protects

The present invention provides a topical preparation containing phenylephrine for substantially stopping local bleeding from a skin wound. The inventors have found that, when applied to the skin in the vicinity of a bleeding wound, a topical preparation of the present invent…

USPTO Abstract

The present invention provides a topical preparation containing phenylephrine for substantially stopping local bleeding from a skin wound. The inventors have found that, when applied to the skin in the vicinity of a bleeding wound, a topical preparation of the present invention will reduce or stop bleeding from the wound by causing vasoconstriction of blood vessels in the skin and the subcutaneous layer. The preparation preferably comprises a cream or ointment containing from about 0.5 to 50% by weight phenylephrine dispersed in an inert carrier, phenylphrine being present as its hydrochloride.

Drugs covered by this patent

Patent Metadata

Patent number
CA2154979A1
Jurisdiction
CA
Classification
—
Expires
1997-01-29
Drug substance claim
No
Drug product claim
No
Assignee
Individual
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.